i-Cubed Launches Innovation Spotlight Series with Early-Stage Startup Alleviate Health
A new event series hosted by i-Cubed promises to forge connections and accelerate promising startups to expedite breakthroughs and improve efficiencies in clinical res
DCRI Unveils New Imaging and Translational Biomarker Evidence in Pulmonary Fibrosis and Lung Disease from the IPF-PRO/ILD-PRO Registry
New evidence and results from eight studies based on data from the IPF-PRO/ILD-PRO Registry was shared by the Duke Clinical Research Institute (DCRI) and its collaborators at the American Tho
Study Confirms No Benefit to Taking Montelukast for COVID-19 Symptoms
Montelukast, commonly used to treat asthma and allergies, is one of five FDA-approved repurposed medications tested in ACTIV-6, a nationwide remote study
3 DCRI Faculty Receive Duke School of Medicine Awards
May 14, 2024 — Three Duke Clinical Research Institute faculty members were honored by the Duke School of Medicine during the school’s annual faculty awards ceremony on Tuesday, May 14.
DCRI Collaborates with Biotechnology Partners to Promote Innovation in Precision Health
May 13, 2024 — The Precision Health Alliance, a new consortium co-founded by the Duke Clinical Research Institute (DCRI), Beam Therapeut
Drug Development for Major Chronic Health Conditions–Aligning With Growing Public Health Needs
New Partnership for Metabolic Platform to Accelerate Weight Loss Research and Treatment
DCRI will partner with the Duke Margolis Institute for Health Policy and Eli Lilly and Company to understand the metabolic landscape and address disparities.
Saghmos Therapeutics Announces Collaboration with Duke Clinical Research Institute to Optimize Phase 3 Cardio-Renal Metabolic Study
DCRI is the world’s largest academic clinical research organization and a pioneer in cardiovascular clinical research, combining clinical an